Showing results (391-400 of 976) with videos related to

Sort By:
Pageof 98
NPJ Breast Cancer|September 1, 2021
Synergistic targeting of BRCA1 mutated breast cancers with PARP and CDK2 inhibitionDiar Aziz, Neil Portman, Kristine J Fernandez, et al.
NPJ Breast Cancer|March 16, 2023
Short-term changes in ultrasound tomography measures of breast density and treatment-associated endocrine symptoms after tamoxifen therapyCody Ramin, Ruth M Pfeiffer, Sharon Fan, et al.
NPJ Breast Cancer|November 5, 2022
Detection of microsatellite instability high (MSI-H) status by targeted plasma-based genotyping in metastatic breast cancerNeelima Vidula, Andrew Lipman, Shumei Kato, et al.
NPJ Breast Cancer|June 23, 2020
Somatic genetic aberrations in benign breast disease and the risk of subsequent breast cancerZexian Zeng, Andy Vo, Xiaoyu Li, et al.
NPJ Breast Cancer|February 13, 2025
Clinico-pathological factors predicting pathological response in early triple-negative breast cancerClara Helal, Lounes Djerroudi, Toulsie Ramtohul, et al.
NPJ Breast Cancer|February 5, 2025
Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapyLuca Mastrantoni, Giovanna Garufi, Giulia Giordano, et al.
NPJ Breast Cancer|November 15, 2024
Baseline gut microbiome alpha diversity predicts chemotherapy-induced gastrointestinal symptoms in patients with breast cancerLauren D Otto-Dobos, Lindsay D Strehle, Brett R Loman, et al.
NPJ Breast Cancer|November 3, 2024
Benefit of systemic therapy in MINDACT patients with small, ER-positive, HER2-negative breast cancersFlorentine S Hilbers, Coralie Poncet, Konstantinos Tryfonidis, et al.
NPJ Breast Cancer|November 21, 2024
Multi-institutional report of trastuzumab deruxtecan and stereotactic radiosurgery for HER2 positive and HER2-low breast cancer brain metastasesVaseem M Khatri, Mariella A Mestres-Villanueva, Sreenija Yarlagadda, et al.
NPJ Breast Cancer|March 8, 2025
Prognostic and molecular multi-platform analysis of CALGB 40603 (Alliance) and public triple-negative breast cancer datasetsBrooke M Felsheim, Aranzazu Fernandez-Martinez, Cheng Fan, et al.
Pageof 98